UnitedHealth Group Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
UnitedHealth Group Stock Forecast and Price Target
The average price target for UnitedHealth Group's stock lately set by several renowned analysts is $562.00, which would result in a potential upside of approximately 15.33% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of $675.00 and a low estimate of $460.00. If you are not interested in UNH stock, you may be interested in its competitors.
15.33% Upside
UnitedHealth Group Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, UnitedHealth Group's Price has fallen from $328.82 to $0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach $548.56 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MSFT Stock Forecast | Microsoft Corp | Buy |
18
|
$409.06 | Buy/Sell | $465.63 | 14.73% |
| AMZN Stock Forecast | Amazon.com Inc | Buy |
13
|
$176.59 | Buy/Sell | $204.68 | 21.18% |
| BRK.A Stock Forecast | Berkshire Hathaway Inc | Outperform |
7
|
$613.42k | Buy/Sell | $621.67k | 5.15% |
| JPM Stock Forecast | JPMorgan Chase | Outperform |
12
|
$193.08 | Buy/Sell | $192.32 | 10.83% |
| ELV Stock Forecast | Elevance Health | Buy |
14
|
$533.73 | Buy/Sell | $567.53 | 13.17% |
UnitedHealth Group Revenue Forecast for 2023 - 2025 - 2030
In the last three years, UnitedHealth Group's Revenue has grown, rising from $257.14B to $371.62B – a growth of 44.52%. In the next year, analysts believe that Revenue will reach $377.64B – an increase of 1.62%. For the next seven years, the forecast is for Revenue to grow by 33.80%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LMT Stock Forecast | Lockheed Martin | Hold |
6
|
$459.14 | Buy/Sell | $483.88 | 6.07% |
| ALV Stock Forecast | Allianz | Outperform |
10
|
266.70€ | Buy/Sell | 267.63€ | 3.67% |
| CVS Stock Forecast | CVS Health | Outperform |
12
|
$67.77 | Buy/Sell | $89.54 | 29.56% |
.jpg)
UnitedHealth Group Dividend per Share Forecast for 2023 - 2025 - 2030
UnitedHealth Group's Dividend per Share has grown In the last three years, rising from $4.83 to $7.29 – a growth of 50.93%. In the following year, 6 experts forecast UnitedHealth Group's Dividend per Share will decrease by 0.82%, to $7.23. For the next seven years, experts predict that UnitedHealth Group's Dividend per Share will grow at a rate of 102.74%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HCA Stock Forecast | HCA Healthcare | Outperform |
18
|
$319.02 | Buy/Sell | $319.61 | 7.74% |
| CS Stock Forecast | AXA | Outperform |
10
|
34.25€ | Buy/Sell | 32.17€ | 8.03% |
| MCK Stock Forecast | McKesson Corp | Outperform |
11
|
$535.42 | Buy/Sell | $510.77 | 5.71% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MUV2 Stock Forecast | Münchener Rückversicherungs-... | Outperform |
9
|
430.60€ | Buy/Sell | 394.57€ | 7.29% |
| AIG Stock Forecast | American International Group | Outperform |
8
|
$74.97 | Buy/Sell | $76.11 | 10.04% |
| BA. Stock Forecast | BAE Systems | Outperform |
10
|
£13.64 | Buy/Sell | £11.69 | 2.05% |
UnitedHealth Group EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, UnitedHealth Group's EBITDA has grown by 43.49%, rising from $24.48B to $35.13B. For the next year, analysts predict that EBITDA will reach $38.48B – an increase of 9.54%. Over the next seven years, experts believe that UnitedHealth Group's EBITDA will grow at a rate of 59.83%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IQV Stock Forecast | IQVIA Holdings | Outperform |
15
|
$240.84 | Buy/Sell | $267.27 | 14.18% |
| CNC Stock Forecast | Centene | Outperform |
11
|
$76.19 | Buy/Sell | $88.33 | 18.13% |
| HUM Stock Forecast | Humana | Outperform |
14
|
$315.98 | Buy/Sell | $426.74 | 17.10% |
UnitedHealth Group EBIT Forecast for 2023 - 2025 - 2030
In the last three years, UnitedHealth Group's EBIT has grown, moving from $22.41B to $32.36B – an increase of 44.42%. In the next year, analysts predict that EBIT will jump to $34.75B – up 7.38% from the current level. Looking ahead to seven years, experts forecast that EBIT will grow by 52.88%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A Stock Forecast | Agilent Technologies | Outperform |
10
|
$137.49 | Buy/Sell | $138.82 | 10.19% |
| G Stock Forecast | Assicurazioni Generali S.p.A. | Hold |
18
|
23.03€ | Buy/Sell | 20.93€ | 0.65% |
| EXPN Stock Forecast | Experian | Outperform |
10
|
£32.62 | Buy/Sell | £39.26 | 39.82% |
UnitedHealth Group EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, UnitedHealth Group's EPS has fallen from $16.88 to $0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach $28.16 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FICO Stock Forecast | Fair Isaac Corp | Hold |
16
|
$1.19k | Buy/Sell | $727.43 | 13.16% |
| CAH Stock Forecast | Cardinal Health Inc | Hold |
13
|
$103.54 | Buy/Sell | $108.07 | 11.07% |
| ICLR Stock Forecast | ICON Public | Buy |
16
|
$309.44 | Buy/Sell | $306.07 | 15.53% |
.jpg)